Advances in AML: The Role of a Targeted Therapy in Current Treatment Paradigms

Host: Charles Turck, PharmD, BCPS, BCCCP <br> Guest: Harry Paul Erba, MD, PhD <br> Guest: Uma Borate, MD, MS <br> <p>With the development of technologies paired with an enhanced understandings of the AML genomic landscape, it’s become possible to develop targeted AML therapies. Joining Dr. Charles Turck to explore Venetoclax and its role in current AML treatment paradigms are Drs. Uma Borate and Harry Erba.</p>